Suzanne McFarlane

1.1k citations
14 papers · 841 indexed · h-index 11

Suzanne McFarlane

13 papers receiving 828 citations

Peers

Suzanne McFarlane
Comparison fields: 5 of 87
  • Immunology and Allergy 110
  • Cell Biology 241
  • Oncology 292
  • Cancer Research 139
  • Ophthalmology 73
Replace Mark G. Slomiany with:
Mark G. Slomiany United States
Natalia Marchenko United States
Berit Olofsson France
Piera Valente Italy
Juliet G. Carbon United States
Roberta Sommaggio Italy
Khalid A. Mohamedali United States
Kimita Suyama United States
Shaija Samuel United States
Lere Bao United States
Suzanne McFarlane relative to Mark G. Slomiany United States Mark G. Slomiany's profile →
Citations per field
00.5×1.5×
Mark G. Slomiany · 1×
Citations per year

Countries citing papers authored by Suzanne McFarlane

Since Specialization
Citations

This map shows the geographic impact of Suzanne McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne McFarlane more than expected).

Fields of papers citing papers by Suzanne McFarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne McFarlane. The network helps show where Suzanne McFarlane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne McFarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne McFarlane Line = papers co-authored together Suzanne McFarlane links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201588
2 201554
3 201446
4 201339
5 201260
6 200873
7 20082
8 2006106
9 20062
10 20061
11 200558
12 200437
13 200477
14 2004198

About Suzanne McFarlane

Suzanne McFarlane is a scholar working on Immunology and Allergy, Cell Biology and Cancer Research, having authored 14 papers that have together received 841 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers), Cancer Cells and Metastasis (2 papers), Ubiquitin and proteasome pathways (2 papers), Protease and Inhibitor Mechanisms (2 papers), Retinal Diseases and Treatments (2 papers), Bone and Dental Protein Studies (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology and Allergy (110 citations), Cell Biology (241 citations) and Oncology (292 citations). Suzanne McFarlane has collaborated with scholars based in United Kingdom, Ireland and Australia. Frequent co-authors include A Hill, David Waugh, Patrick G. Johnston, Cheryl McFarlane, Elaine W. Kay, Anthony O’Grady, G. J. Mahon, Tom A. Gardiner, Mohamed El‐Tanani and Alan W. Stitt. Their work appears in journals such as Oncotarget, Breast Cancer Research, Molecular Cancer Therapeutics, British Journal of Ophthalmology and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026